BioNovix, Inc(TM) Scientifically Supported Wellness Products Launch in Mexico

MeridiumXN(TM) Resource in Fighting Mexico's Number One Cause of Death

The product launch of BioNovix, Inc.(TM) in Mexico was announced today by BioNovix, Inc.(TM) Vice President of Marketing Mark Kanas. "We are honored that Mexico is our first country of expansion for our flagship product MeridiumXN(TM) (liquid formulation) and its associated products," said Kanas. BioNovix, Inc(TM) expects this premiere International launch to be the beginning of creating new partnerships and opportunities for the awareness and availability of MeridiumXN(TM) and its related products throughout the world.

Mexico is ranked as the second most obese country, behind the United States.(1) The time lag between the onset of obesity and increases in related chronic health problems (such as diabetes) suggests that the rise in obesity that has occurred in Mexico will have substantial implications on the future incidence of health problems.(1) The prevalence of diabetes in the Mexican population is shocking and still on the rise. Over 6.5 million Mexicans are diabetic, a figure that is expected to grow to 11 million by 2025.(2) Jose Cordova, Mexico's Health Secretary describes diabetes as Mexico's number one cause of death.(2)

Scientists have been studying how antioxidants affect health for several decades and much research has accumulated. It shows, quite clearly, that a diet with plenty of antioxidants can help to alleviate these conditions. Bionovix's new Meridium XN(TM) addresses these issues, naturally.

Studies show that Hispanics who are indigenous of Mexico are not the only ones at risk. Approximately 10.6 percent of all Mexican Americans (1.2 million) have diabetes. Mexican Americans are 1.9 times more likely to have diabetes than non-Hispanic whites. Other Hispanic/Latino Americans are twice as likely to have diabetes than non-Hispanic whites. Other facts about Hispanic Americans and diabetes include the following:

A study conducted in Mexico City found that subjects living in the city for ten years or more were exposed permanently to air pollution which developed deficient antioxidant capacity to oxidative stress. All of the stress factors mentioned including obesity, diabetes, and pollution create a build up of isoprostanes, and high levels of isoprostanes can result in oxidative stress. Isoprostanes are byproducts of oxidation from free radicals, the same process that makes a piece of apple subjected to air turn brown and go rancid. High isoprostane levels cause higher levels of oxidative stress. There is a correlative relationship between the level of isoprostanes in your system and the level of oxidative stress. In the 17 years since isoprostanes were discovered in 1990, nearly 1,500 studies have been conducted on them. Measuring isoprostane levels is now accepted among scientists as the definitive way to assess oxidative stress.

MeridiumXN(TM) is the first product to make xanthohumol bioavailable. Xanthohumol, a patented extract from the hops flower, in its natural state is difficult to absorb, due to its poor solubility in the gastro-intestinal tract. The xanthohumol in MeridiumXN(TM) has been surrounded by an advanced, easily soluble nanoemulsion that carries the molecule across the GI membranes. The delivery system is so unique, it has been awarded multiple United States patents. BioNovix(TM) has now unleashed the power of xanthohumol by releasing it into the body at a cellular level.

A pilot study on MeridiumXN(TM) found that subjects who took the product for three weeks experienced an average 36 percent drop in their isoprostanes. MeridiumXN(TM) is more than just an antioxidant. According to BioNovix(TM) Chief Science Officer and co-founder Eric Kuhrts, "It helps maintain healthy levels of glucose, insulin, cholesterol and triglycerides -- things a regular antioxidant can't do."

BioNovix(TM) sells its products direct to consumers through a network marketing channel of distribution, offering opportunities to BioNovix Independent Business Consultants to grow their health as well as their income.

"With the launch of MeridiumXN in Mexico, our BioNovix Independent Business Consultants have exclusive access to the first single solution to metabolic stress and overall wellness and the ultimate antidote to the stresses of lifestyle, diet, pollution, exercise and aging," Mr. Auzenne, founder and CEO of BioNovix, stated.

Founded in 2006, BioNovix(TM) is a consumer health products company that develops scientifically sound products to advance health and wellness. MeridiumXN(TM), a patented nutraceutical product that reduces isoprostane (stress) levels, is their flagship product. While BioNovix(TM) is a new company, its founders are well-established, respected professionals in the nutraceutical industry.

For additional information about the BioNovix(TM) line of consumer health products, visit www.bionovix.com; Mark.kanas@bionovix.com (866)469-1246

(1) OECD

(2) Angular-Salinas CA, Vasquez-Chavez C, Gamboa-Marrufo R, Garcia-Soto N, de Jesue Rios-Gonzalez J, Holguin R, Vela S, Ruiz-Alvarez F, Mayagoitia S. Departamento de Endocrinologia y Metabolismo de Lipidos, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico. (August 2007)

Add to Digg Bookmark with del.icio.us Add to Newsvine